glp receptor 1 agonists GLP1 Agonists—Effects beyond Obesity and Diabetes The Landscape Of GLP-1 Receptor
Description
Danish Medicines Agency
Head-to-head trials against semaglutide are recruiting and have not been reported
The primary outcome was MACE, a composite of myocardial infarction, stroke, and all-cause mortality
GIP and GLP-2 together improve bone turnover in humans supporting GIPR-GLP-2R co-agonists as future osteoporosis treatment
